BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11224191)

  • 1. Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone.
    Oliveto AH; Bickel WK; Hughes JR; Terry SY; Higgins ST; Badger GJ
    Behav Pharmacol; 1993 Jun; 4(3):237-246. PubMed ID: 11224191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports.
    Oliveto AH; Bickel WK; Hughes JR; Shea PJ; Higgins ST; Fenwick JW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):885-94. PubMed ID: 1602393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
    Oliveto AH; Rosen MI; Woods SW; Kosten TR
    J Pharmacol Exp Ther; 1995 Jan; 272(1):231-41. PubMed ID: 7815337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload.
    Duka T; Tasker R; Russell K; Stephens DN
    Behav Pharmacol; 1998 May; 9(3):219-29. PubMed ID: 9832936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice.
    Troisi 2nd JR; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1993 Jun; 4(3):217-230. PubMed ID: 11224189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis.
    Kamien JB; Bickel WK; Oliveto AH; Higgins ST; Hughes JR; Richards AT; Badger GJ
    Behav Pharmacol; 1995 Mar; 6(2):187-194. PubMed ID: 11224326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-like effects of anorectics and related compounds in pigeons.
    Evans SM; Johanson CE
    J Pharmacol Exp Ther; 1987 Jun; 241(3):817-25. PubMed ID: 2885408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of the novel anxiolytic buspirone.
    Ator NA
    Behav Pharmacol; 1991 Feb; 2(1):3-14. PubMed ID: 11224042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the discriminative stimulus effects of diazepam in humans.
    Johanson CE
    Behav Pharmacol; 1991 Nov; 2(4 And 5):357-367. PubMed ID: 11224079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam.
    Kamien JB; Bickel WK; Oliveto AH; Smith BJ; Higgins ST; Hughes JR; Badger GJ
    Behav Pharmacol; 1994 Jun; 5(3):315-325. PubMed ID: 11224281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats.
    Powell KR; Picker MJ; Dykstra LA
    Behav Pharmacol; 1994 Jun; 5(3):255-264. PubMed ID: 11224275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues.
    Evans SM; Griffiths RR
    Behav Pharmacol; 1991 Nov; 2(4 And 5):345-356. PubMed ID: 11224078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of diazepam in humans.
    Johanson CE
    J Pharmacol Exp Ther; 1991 May; 257(2):634-43. PubMed ID: 2033509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.